effect of local tranexamic acid in prevention of hematoma formation and swelling after surgery for carpal tunnel syndrome

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT201605242115N4

Enrollment

Registered

2017-08-01

Start date

2017-10-01

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Carpal Tunnel syndrome. Carpal tunnel syndrome

Interventions

Intervention 1: In the intervention group 1 ampule of tranexamic acid is injected into flexor sheet. Intervention 2: In the control group normal saline is used.

Prevention

Treatment - Drugs

In the intervention group 1 ampule of tranexamic acid is injected into flexor sheet.

In the control group normal saline is used.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: inclusion criteria: 1. informed consent for entrance to trial 2. Carpal tunnel syndrome diagnosis requiring surgery exclusion criteria: 1.history of coagulation disorder 2.bilateral surgery 3.hypersensitivity to tranexamic acid

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Hematoma. Timepoint: day after the operation, second and fourth week, 3 months afher the operation. Method of measurement: Wrsit circumference measurement.	—

Secondary

Measure	Time frame
Grip power. Timepoint: first, second and third month after the operation. Method of measurement: Jammar Dynamometer.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAlireza Saied

Kerman University of Medical Sciences

arsaiedmd@yahoo.com+98 34 1223 5011

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026